Germany
· Delayed Price · Currency is EUR Regeneron Pharmaceuticals Statistics
Total Valuation
FRA:RGO has a market cap or net worth of EUR 56.43 billion. The enterprise value is 43.28 billion.
| Market Cap | 56.43B |
| Enterprise Value | 43.28B |
Important Dates
The last earnings date was Friday, May 2, 2025.
| Earnings Date | May 2, 2025 |
| Ex-Dividend Date | May 20, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.13% |
| Shares Change (QoQ) | -2.28% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 101.65M |
Valuation Ratios
The trailing PE ratio is 13.56.
| PE Ratio | 13.56 |
| Forward PE | n/a |
| PS Ratio | 4.33 |
| PB Ratio | 2.08 |
| P/TBV Ratio | 2.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.89, with an EV/FCF ratio of 15.08.
| EV / Earnings | 10.40 |
| EV / Sales | 3.48 |
| EV / EBITDA | 10.89 |
| EV / EBIT | 12.34 |
| EV / FCF | 15.08 |
Financial Position
The company has a current ratio of 4.93, with a Debt / Equity ratio of 0.09.
| Current Ratio | 4.93 |
| Quick Ratio | 3.90 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | 0.60 |
| Debt / FCF | 0.87 |
| Interest Coverage | 83.17 |
Financial Efficiency
Return on equity (ROE) is 15.96% and return on invested capital (ROIC) is 8.04%.
| Return on Equity (ROE) | 15.96% |
| Return on Assets (ROA) | 6.91% |
| Return on Invested Capital (ROIC) | 8.04% |
| Return on Capital Employed (ROCE) | 11.70% |
| Revenue Per Employee | 859,750 |
| Profits Per Employee | 274,624 |
| Employee Count | 15,106 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 2.44 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.35% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -35.35% |
| 50-Day Moving Average | 585.89 |
| 200-Day Moving Average | 780.87 |
| Relative Strength Index (RSI) | 50.20 |
| Average Volume (20 Days) | 13 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.44 |
Income Statement
In the last 12 months, FRA:RGO had revenue of EUR 13.03 billion and earned 4.16 billion in profits. Earnings per share was 36.48.
| Revenue | 13.03B |
| Gross Profit | 6.36B |
| Operating Income | 3.68B |
| Pretax Income | 4.61B |
| Net Income | 4.16B |
| EBITDA | 4.14B |
| EBIT | 3.68B |
| Earnings Per Share (EPS) | 36.48 |
Balance Sheet
The company has 7.72 billion in cash and 2.50 billion in debt, giving a net cash position of 13.80 billion.
| Cash & Cash Equivalents | 7.72B |
| Total Debt | 2.50B |
| Net Cash | 13.80B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 27.19B |
| Book Value Per Share | 256.75 |
| Working Capital | 12.96B |
Cash Flow
In the last 12 months, operating cash flow was 3.66 billion and capital expenditures -787.62 million, giving a free cash flow of 2.87 billion.
| Operating Cash Flow | 3.66B |
| Capital Expenditures | -787.62M |
| Free Cash Flow | 2.87B |
| FCF Per Share | n/a |
Margins
Gross margin is 48.80%, with operating and profit margins of 28.22% and 31.94%.
| Gross Margin | 48.80% |
| Operating Margin | 28.22% |
| Pretax Margin | 35.38% |
| Profit Margin | 31.94% |
| EBITDA Margin | 31.74% |
| EBIT Margin | 28.22% |
| FCF Margin | 22.02% |
Dividends & Yields
This stock pays an annual dividend of 0.85, which amounts to a dividend yield of 0.17%.
| Dividend Per Share | 0.85 |
| Dividend Yield | 0.17% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 2.08% |
| Buyback Yield | -0.13% |
| Shareholder Yield | 0.04% |
| Earnings Yield | 7.38% |
| FCF Yield | 5.09% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:RGO has an Altman Z-Score of 9.55.
| Altman Z-Score | 9.55 |
| Piotroski F-Score | n/a |